Published in Brain Res on September 25, 1999
Menstrual phase effects on smoking relapse. Addiction (2008) 2.33
Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women. Hum Mol Genet (2005) 1.24
Parkinson's disease as a disconnection syndrome. Neuropsychol Rev (2010) 1.17
Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep (2009) 0.95
Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct (2013) 0.92
Nicotine withdrawal and craving in adolescents: effects of sex and hormonal contraceptive use. Addict Behav (2009) 0.91
Neural mechanisms of reproduction in females as a predisposing factor for drug addiction. Front Neuroendocrinol (2010) 0.85
Polymorphism in the Vesicular Monoamine Transporter 2 Gene Decreases the Risk of Parkinson's Disease in Han Chinese Men. Parkinsons Dis (2015) 0.76
Male/Female differences in neuroprotection and neuromodulation of brain dopamine. Front Endocrinol (Lausanne) (2011) 0.76
Survey of cadaveric donor application files: 1978-1993. Clin Anat (1998) 1.06
Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Neuroscience (2001) 0.91
Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J Neural Transm (Vienna) (2003) 0.90
Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp Neurol (1994) 0.88
Bimodal effect of progesterone on in vitro dopamine function of the rat corpus striatum. Neuroendocrinology (1984) 0.86
Male vole urine changes luteinizing hormone-releasing hormone and norepinephrine in female olfactory bulb. Science (1981) 0.86
Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice. Neuropharmacology (2003) 0.85
Age related changes of social memory/recognition in male Fischer 344 rats. Behav Brain Res (1994) 0.85
Inhibition of striatal dopamine transporter activity by 17beta-estradiol. Eur J Pharmacol (1998) 0.85
Effects of progesterone and its metabolites on neuronal membranes. Ciba Found Symp (1990) 0.84
Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice. J Neuroendocrinol (2007) 0.83
Age-dependent changes in olfactory-mediated behavioral investigations in the male rat. Behav Neural Biol (1992) 0.83
Age-related size reduction of foramina in the cribriform plate. Anat Rec (1998) 0.82
Alteration in L-DOPA evoked dopamine and DOPAC output under conditions of impaired vesicular dopamine storage. J Neural Transm (Vienna) (1998) 0.82
Nisoxetine infusion into the olfactory bulb enhances the capacity for male rats to identify conspecifics. Neuroscience (2001) 0.82
Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release. Brain Res (1997) 0.81
The effect of hormonal condition on dose-dependent amphetamine-stimulated behaviors in the male rat. Horm Behav (1986) 0.80
In vivo activity of the LHRH pulse generator as determined with push-pull perfusion of the anterior pituitary gland of unrestrained intact and castrate male rats. Neuroendocrinology (1987) 0.80
Role of olfactory bulb norepinephrine in the identification and recognition of chemical cues. Physiol Behav (1993) 0.80
The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Brain Res (2001) 0.80
Ovarian hormones regulating sexual and social behaviors in female prairie voles, Microtus ochrogaster. Physiol Behav (1979) 0.79
Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice. Neuroscience (2005) 0.79
Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats. Brain Res (2000) 0.79
The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation. Exp Neurol (2000) 0.79
Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice. Horm Behav (1994) 0.78
Inactivation of one copy of the mouse neurotrophin-3 gene induces cardiac sympathetic deficits. Physiol Genomics (2000) 0.78
Aging and sex differences in striatal dopaminergic function. Neuroscience (2007) 0.77
Estrogen modulates responses of striatal dopamine neurons to MPP(+): evaluations using in vitro and in vivo techniques. Brain Res (2000) 0.77
L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats. J Neural Transm (Vienna) (1996) 0.77
Castration differentially alters [3H]nisoxetine binding to norepinephrine uptake sites in olfactory bulb and frontal cortex of male rats. Synapse (1999) 0.76
A functional dimorphism in the response of the hypothalamic-pituitary axis of prepubertal rats to steroid treatment. Biol Reprod (1982) 0.76
Photoperiod and steroid-dependent adjustments in hypothalamic gonadotropic hormone-releasing hormone, dopamine, and norepinephrine content in male deer mice. Biol Reprod (1997) 0.76
A miniaturized push-pull cannula for use in conscious, unrestrained animals. Pharmacol Biochem Behav (1986) 0.76
Tamoxifen alters dopamine output through direct actions upon superfused corpus striatal tissue fragments. Neurochem Int (1998) 0.75
Tamoxifen treatment of ovariectomized mice alters dopamine release from striatal tissue fragments superfused in vitro. Brain Res (1995) 0.75
Interactive effects of tamoxifen and oestrogen upon the nigrostriatal dopaminergic system: long-term treatments. J Neuroendocrinol (1999) 0.75
Interactive effects of tamoxifen and estrogen upon the nigrostriatal dopaminergic system. Neuroendocrinology (1997) 0.75
Methamphetamine produces subsequent reductions in running time to exhaustion in mice. Brain Res (2001) 0.75
Prolactin stimulates dopamine release from the rat corpus striatum in the absence of extra-cellular calcium. Neurosci Lett (1991) 0.75
Alteration of dopamine release by rat caudate putamen tissues superfused with alpha 2-macroglobulin. J Neurosci Res (1996) 0.75
In-vivo activity of the LH-releasing hormone pulse generator in castrated and intact male rats. J Endocrinol (1985) 0.75
Ablation of the hypothalamic arcuate-median eminence region reduces the concentration of vasoactive intestinal peptide in the anterior pituitary gland of male rats. Brain Res (1993) 0.75
Transient changes in the in vitro activity of the luteinizing hormone-releasing hormone pulse generator after ovariectomy in rats. Endocrinology (1986) 0.75
Release of luteinizing hormone-releasing hormone (LHRH) and neuroactive substances in unanesthetized animals as estimated with push-pull cannulae (PPC). Biol Reprod (1987) 0.75
Presence and localization of immunoreactive luteinizing hormone-releasing hormone (LHRH) within the olfactory bulbs of adult male and female rats. Peptides (1981) 0.75
Monoamine-activated alpha 2-macroglobulin inhibits neurite outgrowth, survival, choline acetyltransferase, and dopamine concentration of neurons by blocking neurotrophin-receptor (trk) phosphorylation and signal transduction. Ann N Y Acad Sci (1994) 0.75
Aging alters opiate inhibition of potassium (K+)-stimulated dopamine release from the corpus striatum of male rats. Neurobiol Aging (1990) 0.75
Localized and discrete changes in neuropeptide (LHRH and TRH) and neurotransmitter (NE and DA) concentrations within the olfactory bulbs of male mice as a function of social interaction. Horm Behav (1983) 0.75
L-dopa reverses castration-induced disruption of dishabituation responses to female chemical cues in male rats. Pharmacol Biochem Behav (1994) 0.75
Intracranial infusion of monoamine-activated alpha 2-macroglobulin decreases dopamine concentrations within the rat caudate putamen. J Neurosci Res (1994) 0.75
Castration reduces olfactory bulb norepinephrine transporter function as indicated by responses to noradrenergic uptake blockers. Brain Res (1998) 0.75
Para-chlorophenylalanine treatment inhibits the expression of vasoactive intestinal peptide messenger RNA in rat anterior pituitary. Brain Res Mol Brain Res (1993) 0.75
Inhibition of dopamine and choline acetyltransferase concentrations in rat CNS neurons by rat alpha 1- and alpha 2-macroglobulins. J Neurosci Res (1998) 0.75
In vivo LH-RH output of ovariectomized rats following estrogen treatment. Neuroendocrinology (1986) 0.75